News Image

RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System

Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process, Further Accelerating Commercialization Strategy

RenovoRx Estimates Initial Target Market Size for RenovoCath of Several Hundred Million Dollars in Annual Sales

Read more at globenewswire.com

RENOVORX INC

NASDAQ:RNXT (2/7/2025, 8:00:01 PM)

After market: 1.16 0 (0%)

1.16

-0.3 (-20.55%)

RNXT Latest News and Analysis

ChartMill News Image16 hours ago - ChartmillWhat's going on in today's pre-market session

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

ChartMill News Imagea day ago - ChartmillThese stocks are moving in today's after hours session

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Follow ChartMill for more